Integration of Three-dimensional Echocardiography and Fluoroscopy Imaging During the Percutaneous Closure of intAtrial Septal Defects in Children: CIA-3D-navigator.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Septal Defects
- Sponsor
- University Hospital, Toulouse
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Validity of the image fusion.
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The interventional catheterization allows the percutaneous treatment of congenital heart diseases as the atrial septal defect (ASD). The examination is guided by the X-rays with stochastic side effects worrying at the child's. The software "Echonavigator" allows to merge the ultrasound image and fluoroscopic. This innovative software facilitates the procedures and reduce the irradiation time in some adult procedures.
The aim of this study was to validate the image fusion in children.
Detailed Description
The software "Echonavigator" will be used after the introduction of the percutaneous closure of ASD prosthesis. The image fusion on fluoroscopy will then be applied and the bias between the generated ultrasound image and the X-ray view of the prosthesis will be measured. The center marker visible prosthesis ultrasound and fluoroscopy used as a reference marker.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Weight higher than or equal to 20 kg
- •Presence of an ostium secundum atrial septal defect diagnosed by transthoracic echocardiography and associated with a shunt from left to right evidenced by the significant dilation of the right cavities liable to a closure
- •The ASD should have an anatomy allowing percutaneous closure according to international recommendations
Exclusion Criteria
- •Children with contraindication to transesophageal ultrasound according to international recommendations
- •ADS with minor shunt without indication of closure
- •Refusal to participate in the study expressed by parental authority
Outcomes
Primary Outcomes
Validity of the image fusion.
Time Frame: Day 1
Through the fusion image will be measured by a fixed mark in 4 mm implications. This bias will be averaged in absolute terms and compared to zero through reference. The bias will be measured by two methods: one using the tool positioning an echo point of interest later merged fluoroscopy, the other using a fusion of 3D image possible with the second version. The method will be considered valid if the bias is not significantly different from 0 with a tolerance of 2 mm by 2 methods.
Secondary Outcomes
- Feasibility assessed by the number and percentage (calculated with the 95% confidence interval) for procedures for which the image fusion of the prosthesis of CIA has been successfully obtained will be noted.(Day1)